𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progression

✍ Scribed by Mohammad R. Shaker; Guang Yang; Terry L. Timme; Sang H. Park; Dov Kadmon; Chengzhen Ren; Xiaorong Ji; Hon-Man Lee; Inder Sehgal; Mario Anzano; Michael B. Sporn; Timothy C. Thompson

Book ID
110295429
Publisher
Springer
Year
2000
Tongue
English
Weight
232 KB
Volume
18
Category
Article
ISSN
0262-0898

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The effects of RANK blockade and osteocl
The effects of RANK blockade and osteoclast depletion in a model of pure osteoblastic prostate cancer metastasis in bone
✍ Peter G. Whang; Edward M. Schwarz; Seth C. Gamradt; William C. Dougall; Jay R. L πŸ“‚ Article πŸ“… 2005 πŸ› Elsevier Science 🌐 English βš– 984 KB

Adenocarcinoma of the prostate exhibits a clear propensity for bone and is associated with the formation of osteoblastic metastases. It has previously been suggested that osteoclast activity may be necessary for the development of these osteoblastic metastases based on data from lytic and mixed lyti

Orthotopic treatment model of prostate c
Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: Efficacy of flt3 ligand immunotherapy
✍ Kenneth D. Somers; Roy R. Brown; Daniel A. Holterman; Nazita Yousefieh; William πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 376 KB πŸ‘ 1 views

## Abstract We established an orthotopic treatment model of prostate cancer to generate reproducible primary and metastatic carcinoma in immunocompetent C57BL/6 mice. Using an __in vivo__ selection scheme of intraprostatic implantation of TRAMP‐C1 cells, primary prostate tumors were cultured and re

In vivo MRI of cancer cell fate at the s
In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brain
✍ Chris Heyn; John A. Ronald; Soha S. Ramadan; Jonatan A. Snir; Andrea M. Barry; L πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 724 KB

## Abstract Metastasis (the spread of cancer from a primary tumor to secondary organs) is responsible for most cancer deaths. The ability to follow the fate of a population of tumor cells over time in an experimental animal would provide a powerful new way to monitor the metastatic process. Here we

Polymorphisms of fibroblast growth facto
Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population
✍ Zhiyong Ma; Norihiko Tsuchiya; Takeshi Yuasa; Takamitsu Inoue; Teruaki Kumazawa; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 138 KB πŸ‘ 1 views

## Abstract Fibroblast growth factor receptor 4 (FGFR4) is a member of a family of transmembrane receptors with ligand‐induced tyrosine kinase activity. The Glycine (Gly) to Arginine (Arg) polymorphism at codon 388 (Gly388Arg), which encodes an amino acid in the transmembrane part of the FGFR4 gene

Gene-directed enzyme prodrug therapy for
Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease
✍ Rosetta Martiniello-Wilks; Allison Dane; Dale J. Voeks; Geetha Jeyakumar; Elin M πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 310 KB πŸ‘ 1 views

## Abstract ## Background Gene‐directed enzyme prodrug therapy (GDEPT) based on the __E. coli__ enzyme purine nucleoside phosphorylase (PNP) represents a new approach for treating slow growing tumours like prostate cancer (PCa). Expressed enzyme converts a systemically administered prodrug, fludar